Biomarkers as tools in human health risk assessment, Clin Chem, vol.41, pp.1804-1808, 1995. ,
Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture, Cancer Res, vol.42, pp.4875-917, 1982. ,
Mechanisms of carcinogenesis: dose response, J Environ Pathol Toxicol, vol.1, pp.163-179, 1977. ,
Implication of nonlinear kinetics on risk estimation in carcinogenesis, Science, vol.219, issue.4588, pp.1032-1037, 1983. ,
DOI : 10.1126/science.6823565
Risk Assessment of Carcinogenic and Noncarcinogenic Chemicals, Critical Reviews in Toxicology, vol.18, issue.84, pp.341-367, 1990. ,
DOI : 10.1080/00022470.1983.10465651
A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: Example???Vinyl chloride, Toxicology and Applied Pharmacology, vol.55, issue.1, pp.154-161, 1980. ,
DOI : 10.1016/0041-008X(80)90231-8
Pharmacokinetics and Risk Assessment In: Toxicology and Risk Assessment; Principles, pp.81-99, 1996. ,
Implementation of EPA Revised Cancer Assessment Guidelines: Incorporation of Mechanistic and Pharmacokinetic Data, Toxicological Sciences, vol.37, issue.1, pp.16-36, 1997. ,
DOI : 10.1093/toxsci/37.1.16
An introduction to the use of physiologically based pharmacokinetic models in risk assessment, Statistical Methods in Medical Research, vol.91, issue.4, pp.341-358, 1997. ,
DOI : 10.1177/096228029700600404
Pharmacokinetic Modeling Approaches for Describing the Uptake, Systemic Distribution, and Disposition of Inhaled Chemicals, Critical Reviews in Toxicology, vol.150, issue.3, pp.237-254, 1995. ,
DOI : 10.1080/15287399109531480
Physiologically based pharmacokinetics and the risk assessment process for methylene chloride, Toxicology and Applied Pharmacology, vol.87, issue.2, pp.185-205, 1987. ,
DOI : 10.1016/0041-008X(87)90281-X
A Trichloroethylene Risk Assessment Using a Monte Carlo Analysis of Parameter Uncertainty in Conjunction with Physiologically-Based Pharmacokinetic Modeling, Risk Analysis, vol.15, issue.5, pp.555-565, 1995. ,
DOI : 10.1016/0041-008X(90)90357-Z
Effects of the structure of a toxicokinetic model of butadiene inhalation exposure on computed production of carcinogenic intermediates, Toxicology, vol.113, issue.1-3, pp.31-39, 1996. ,
DOI : 10.1016/0300-483X(96)03424-5
Interspecies Extrapolation of Physiological Pharmacokinetic Parameter Distributions, Risk Analysis, vol.75, issue.6, pp.741-754, 1996. ,
DOI : 10.1016/0378-4274(93)90103-5
1,3-Butadiene working group report, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.330, issue.1-2, pp.101-114, 1995. ,
DOI : 10.1016/0027-5107(95)00038-K
A Parallelogram Approach for Safety Evaluation of Ingested Acetaldehyde, Regulatory Toxicology and Pharmacology, vol.24, issue.3, pp.251-263, 1996. ,
DOI : 10.1006/rtph.1996.0138
Achieving credibility in risk assessment models, Toxicology Letters, vol.79, issue.1-3, pp.107-114, 1995. ,
DOI : 10.1016/0378-4274(95)03362-O
Variability of Safe Dose Estimates When Using Complicated Models of the Carcinogenic Process, Toxicological Sciences, vol.13, issue.3, pp.533-544, 1989. ,
DOI : 10.1093/toxsci/13.3.533
Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output, Toxicology Letters, vol.49, issue.2-3, pp.371-385, 1989. ,
DOI : 10.1016/0378-4274(89)90044-1
Precision and sensitivity of pharmacokinetic models for cancer risk assessment: Tetrachloroethylene in mice, rats, and humans, Toxicology and Applied Pharmacology, vol.102, issue.2, pp.300-315, 1990. ,
DOI : 10.1016/0041-008X(90)90029-T
Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform, Toxicology, vol.111, issue.1-3, pp.289-303, 1996. ,
DOI : 10.1016/0300-483X(96)03383-5
Structure and Parameterization of Pharmacokinetic Models: Their Impact on Model Predictions, Risk Analysis, vol.8, issue.2, pp.189-201, 1992. ,
DOI : 10.1016/0378-4274(91)90157-2
Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE), Toxicology Letters, vol.68, issue.1-2, pp.131-144, 1993. ,
DOI : 10.1016/0378-4274(93)90126-I
Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results, Environmental Health Perspectives, vol.102, issue.Suppl 11, pp.61-66, 1994. ,
DOI : 10.1289/ehp.94102s1161
Uncertainty, Variability, and Sensitivity Analysis in Physiological Pharmacokinetic Models, Journal of Biopharmaceutical Statistics, vol.19, issue.3, pp.245-271, 1995. ,
DOI : 10.2307/2289528
Variability in Biological Exposure Indices Using Physiologically Based Pharmacokinetic Modeling and Monte Carlo Simulation, American Industrial Hygiene Association Journal, vol.57, issue.1, pp.23-32, 1996. ,
DOI : 10.1080/15428119691015188
Assessing, Accommodating, and Interpreting the Influences of Heterogeneity, Environmental Health Perspectives, vol.90, pp.215-222, 1991. ,
DOI : 10.2307/3430871
Metabolic Constants for Chloroform, Toxicological Sciences, vol.25, issue.1, pp.29-44, 1995. ,
DOI : 10.1093/toxsci/25.1.29
Review Physiological pharmacokinetic modelling, Xenobiotica, vol.18, issue.11, pp.1241-1257, 1990. ,
DOI : 10.3109/03602538409033558
Trichloroethylene exposure. Simulation of uptake, excretion, and metabolism using a mathematical model., Occupational and Environmental Medicine, vol.34, issue.1, pp.43-55, 1977. ,
DOI : 10.1136/oem.34.1.43
A physiologically-based description of the inhalation pharmacokinetics of styrene monomer in rats and humans, Toxicology Letters, vol.18, pp.415-418, 1983. ,
DOI : 10.1016/0378-4274(83)90559-3
Human styrene exposure, International Archives of Occupational and Environmental Health, vol.32, issue.2, pp.19-36, 1983. ,
DOI : 10.1007/BF00406174
Physiological pharmacokinetic models: principles, applications, limitations and outlook, Methods Find Exp Clin Pharmacol, vol.8, pp.603-614, 1986. ,
A Physiologically Based Pharmacokinetic Model for Methyl Mercury in the Pregnant Rat and Fetus, Toxicology and Applied Pharmacology, vol.132, issue.1, pp.91-102, 1995. ,
DOI : 10.1006/taap.1995.1090
The Importance of Anatomical Realism for Validation of Physiological Models of Disposition of Inhaled Toxicants, Toxicology and Applied Pharmacology, vol.147, issue.2, pp.448-458, 1997. ,
DOI : 10.1006/taap.1997.8289
Population toxicokinetics of tetrachloroethylene, Archives of Toxicology, vol.70, issue.6, pp.347-355, 1996. ,
DOI : 10.1007/s002040050284
URL : https://hal.archives-ouvertes.fr/ineris-00969532
Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions, Journal of the American Statistical Association, vol.55, issue.436, pp.1400-1412, 1996. ,
DOI : 10.2307/2533402
A physiological model for the pharmacokinetics of methylene chloride in B6C3F1 mice following i.v. administrations, Journal of Pharmacokinetics and Biopharmaceutics, vol.6, issue.4, pp.413-436, 1984. ,
DOI : 10.1007/BF01062666
Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model, Drug Metab Dispos, vol.12, pp.527-535, 1984. ,
Physiologically based pharmacokinetic modeling of inhaled 2-butoxyethanol in man, Toxicology Letters, vol.34, issue.1, pp.23-31, 1986. ,
DOI : 10.1016/0378-4274(86)90141-4
A Physiologically Based Pharmacokinetic Assessment of Tetrachloroethylene in Groundwater for a Bathing and Showering Determination, Risk Analysis, vol.8, issue.1, pp.37-49, 1993. ,
DOI : 10.1016/0041-008X(88)90030-0
A Distributed Parameter Physiologically-Based Pharmacokinetic Model for Dermal and Inhalation Exposure to Volatile Organic Compounds, Risk Analysis, vol.31, issue.6, pp.147-160, 1996. ,
DOI : 10.1016/0041-008X(90)90324-N
Effect of physical exercise on uptake, distribution and elimination of vapors in man In: Modeling of Inhalation Exposure to Vapors: Uptake, Distribution, and Elimination (Fiserova-Bergerova F, ed), Boca Raton, pp.107-130, 1983. ,
A physiologically based kinetic model of rat and mouse gestation: Disposition of a weak acid, Toxicology and Applied Pharmacology, vol.112, issue.2, pp.245-256, 1992. ,
DOI : 10.1016/0041-008X(92)90194-W
A physiologically based pharmacokinetic computer model for human pregnancy, Teratology, vol.56, issue.2, pp.90-103, 1994. ,
DOI : 10.1002/tera.1420490205
Physiologically Based Pharmacokinetic Models in Developmental Toxicology, Risk Analysis, vol.104, issue.4, pp.605-611, 1994. ,
DOI : 10.1007/BF01060056
Development of a Physiologically Based Pharmacokinetic Model Describing 2-Methoxyacetic Acid Disposition in the Pregnant Mouse, Toxicology and Applied Pharmacology, vol.132, issue.1, pp.103-114, 1995. ,
DOI : 10.1006/taap.1995.1091
Incorporation of Temporal Factors Into Physiologically Based Kinetic Models for Risk Assessment, Inhalation Toxicology, vol.12, issue.6, pp.917-925, 1995. ,
DOI : 10.1289/ehp.747155
Physiologically based pharmacokinetic models applicable to organogenesis: extrapolation between species and potential use in prenatal toxicity risk assessments, Toxicology Letters, vol.82, issue.83, pp.539-547, 1995. ,
DOI : 10.1016/0378-4274(95)03499-4
A computer model and program for xenobiotic disposition during pregnancy, Computer Methods and Programs in Biomedicine, vol.53, issue.3, pp.201-224, 1997. ,
DOI : 10.1016/S0169-2607(97)00020-5
An inhalation distribution model for the lactating mother and nursing child, Toxicology Letters, vol.43, issue.1-3, pp.23-29, 1988. ,
DOI : 10.1016/0378-4274(88)90018-5
Lactational Transfer of Tetrachloroethylene in Rats, Risk Analysis, vol.23, issue.356, pp.339-349, 1994. ,
DOI : 10.1016/0378-4274(88)90018-5
Improving the biological basis for carcinogen risk assessment: benzene-induced leukemia as a case study, 1998. ,
Estimation of occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model, Environmental Health Perspectives, vol.106, issue.Suppl 2, pp.743-753, 1998. ,
DOI : 10.1289/ehp.98106743
Quantitative Relations in the Physiological Constitutions of Mammals, Science, vol.109, issue.2841, pp.579-585, 1949. ,
DOI : 10.1126/science.109.2841.579
Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics, Journal of Pharmacokinetics and Biopharmaceutics, vol.87, issue.2, pp.201-227, 1982. ,
DOI : 10.1007/BF01062336
Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative Paradigm, Drug Metabolism Reviews, vol.108, issue.6213, pp.1071-1121, 1984. ,
DOI : 10.1002/jps.2600570814
Biological basis for extrapolation across mammalian species, Regulatory Toxicology and Pharmacology, vol.6, issue.3, pp.211-237, 1986. ,
DOI : 10.1016/0273-2300(86)90014-0
Man versus Beast: Pharmacokinetic Scaling in Mammals, Journal of Pharmaceutical Sciences, vol.75, issue.11, pp.1028-1040, 1986. ,
DOI : 10.1002/jps.2600751104
Interspecies scaling and comparisons in drug development and toxicokinetics, Xenobiotica, vol.75, issue.11, pp.1201-1231, 1990. ,
DOI : 10.3109/03602538409033558
Parameter and structural identifiability concepts and ambiguities: a critical review and analysis, Am J Physiol, vol.242, issue.5, pp.7-24, 1980. ,
Identifiability, Fed Proc, vol.46, issue.8, pp.2477-2480, 1987. ,
DOI : 10.1016/S1043-4526(08)60036-4
Parameter estimation: local identifiability of parameters, Am J Physiol, vol.258, issue.4, pp.727-736, 1990. ,
Identifiability and indistinguishability of nonlinear pharmacokinetic models, Journal of Pharmacokinetics and Biopharmaceutics, vol.22, issue.3, pp.229-251, 1994. ,
DOI : 10.1007/BF02353330
Structural Identifiability of PBPK Models: Practical Consequences for Modeling Strategies and Study Designs, Critical Reviews in Toxicology, vol.48, issue.3, pp.261-272, 1997. ,
DOI : 10.3109/10408449709089895
A comparison of techniques for the estimation of model prediction uncertainty, Ecological Modelling, vol.115, issue.1, pp.45-59, 1999. ,
DOI : 10.1016/S0304-3800(98)00174-4
Understanding Uncertainty, Risk Analysis, vol.14, issue.5, pp.743-750, 1994. ,
DOI : 10.1111/j.1539-6924.1994.tb00284.x
Optimal statistical design for toxicokinetic studies, Statistical Methods in Medical Research, vol.3, issue.11, pp.359-376, 1997. ,
DOI : 10.1177/096228029700600405
Optimal design for a study of butadiene toxicokinetics in humans, Toxicological Sciences, vol.49, issue.2, pp.213-224, 1999. ,
DOI : 10.1093/toxsci/49.2.213
URL : https://hal.archives-ouvertes.fr/ineris-00962757
Methodology of population pharmacokinetics, In: Drug Fate and Metabolism Hirtz J, vol.5, pp.135-183, 1985. ,
Population Models, Statistical Methodology in the Pharmaceutical Sciences ,
DOI : 10.1201/b16950-6
The Effect of Neglecting Correlations When Propagating Uncertainty and Estimating the Population Distribution of Risk, Risk Analysis, vol.12, issue.4, pp.467-474, 1992. ,
DOI : 10.1016/0951-8320(89)90013-6
Modeling Benzene Pharmacokinetics Across Three Sets of Animal Data: Parametric Sensitivity and Risk Implications, Risk Analysis, vol.74, issue.4, pp.641-654, 1991. ,
DOI : 10.1016/0041-008X(84)90064-4
Sensitivity analysis for physiologically based pharmacokinetic models, Journal of Pharmacokinetics and Biopharmaceutics, vol.17, issue.1, pp.1-20, 1991. ,
DOI : 10.1007/BF01062190
Simulation and the Monte Carlo Method, 1981. ,
Monte Carlo Methods, 1964. ,
Propagation of Uncertainty in Risk Assessments: The Need to Distinguish Between Uncertainty Due to Lack of Knowledge and Uncertainty Due to Variability, Risk Analysis, vol.57, issue.104, pp.707-712, 1994. ,
DOI : 10.1111/j.1539-6924.1994.tb00281.x
Estimating population kinetics, CRC Crit Rev Biomed Eng, vol.8, pp.195-222, 1982. ,
The Population Approach to Pharmacokinetic Data Analysis: Rationale and Standard Data Analysis Methods, Drug Metabolism Reviews, vol.27, issue.1-2, pp.153-171, 1984. ,
DOI : 10.1214/aoms/1177706645
Population Pharmacokinetic/Pharmacodynamic Methodology and Applications: A Bibliography, Biometrics, vol.50, issue.2, pp.566-575, 1994. ,
DOI : 10.2307/2533402
Nonlinear Models for Repeated Measurements Data, 1995. ,
Population toxicokinetics of benzene, Environmental Health Perspectives, vol.104, issue.Suppl 6, pp.1405-1411, 1996. ,
DOI : 10.1289/ehp.961041405
Variability in biological monitoring of solvent exposure. I: Development and validation of a population model, Br J Ind Med, vol.46, pp.447-460, 1989. ,
Variability in biological monitoring of organic solvent exposure. II. Application of a population physiological model., Occupational and Environmental Medicine, vol.46, issue.8, pp.547-558, 1989. ,
DOI : 10.1136/oem.46.8.547
Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine, Journal of Pharmacokinetics and Biopharmaceutics, vol.14, issue.3, pp.311-327, 1988. ,
DOI : 10.1007/BF01062140
Nonparametric EM Algorithms for estimating prior distributions, Applied Mathematics and Computation, vol.45, issue.2, pp.141-157, 1991. ,
DOI : 10.1016/0096-3003(91)90077-Z
Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine, Journal of Pharmacokinetics and Biopharmaceutics, vol.11, issue.60, pp.529-556, 1992. ,
DOI : 10.1007/BF01061470
A maximum likelihood estimation method for random coefficient regression models, Biometrika, vol.73, issue.3, pp.645-656, 1986. ,
DOI : 10.1093/biomet/73.3.645
Nonlinear Mixed Effects Models for Repeated Measures Data, Biometrics, vol.46, issue.3, pp.673-687, 1990. ,
DOI : 10.2307/2532087
A Bayesian Approach to Nonlinear Random Effects Models, Biometrics, vol.41, issue.4, pp.1015-1023, 1985. ,
DOI : 10.2307/2530972
Bayesian Analysis of Linear and Non-Linear Population Models by Using the Gibbs Sampler, Applied Statistics, vol.43, issue.1, pp.201-221, 1994. ,
DOI : 10.2307/2986121
Bayesian Theory, 1994. ,
DOI : 10.1002/9780470316870
Bayesian Data Analysis, 1995. ,
Methods in health service research: An introduction to bayesian methods in health technology assessment, BMJ, vol.319, issue.7208, pp.508-512, 1999. ,
DOI : 10.1136/bmj.319.7208.508
Local computations with probabilities on graphical structures and their application to expert systems, J Roy Stat Soc B, vol.50, pp.157-194, 1988. ,
Graphical Models in Applied Mutivariate Analysis, 1990. ,
Causal diagrams for empirical research, Biometrika, vol.82, issue.4, pp.669-710, 1995. ,
DOI : 10.1093/biomet/82.4.669
Markov chain Monte Carlo methods in biostatistics, Statistical Methods in Medical Research, vol.80, issue.4, pp.339-355, 1996. ,
DOI : 10.1177/096228029600500402
Markov Chain Monte Carlo in Practice, 1996. ,
Kinetics of tetrachloroethylene in volunteers; influence of exposure concentration and work load, International Archives of Occupational and Environmental Health, vol.20, issue.3-4, pp.303-309, 1979. ,
DOI : 10.1007/BF00377784
Some Remarks on Noninformative Priors, Journal of the American Statistical Association, vol.25, issue.432, pp.1357-1363, 1995. ,
DOI : 10.1016/0378-3758(94)90023-X
The Selection of Prior Distributions by Formal Rules, Journal of the American Statistical Association, vol.36, issue.435, pp.1343-1370, 1996. ,
DOI : 10.1080/01621459.1996.10477003
Bayesian Inference in Statistical Analysis, 1973. ,
DOI : 10.1002/9781118033197
Bayesian Computational Methods, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, vol.337, issue.1647, pp.369-386, 1991. ,
DOI : 10.1098/rsta.1991.0130
Inference from Iterative Simulation Using Multiple Sequences, Statistical Science, vol.7, issue.4, pp.457-511, 1992. ,
DOI : 10.1214/ss/1177011136
Markov Chain Monte Carlo Convergence Diagnostics: A Comparative Review, Journal of the American Statistical Association, vol.90, issue.434, pp.883-904, 1996. ,
DOI : 10.1080/01621459.1996.10476956
Annealing Markov Chain Monte Carlo with Applications to Ancestral Inference, Journal of the American Statistical Association, vol.167, issue.431, pp.909-920, 1995. ,
DOI : 10.1080/01621459.1995.10476507
Strategies for improving MCMC In: Markov Chain Monte Carlo in Practice, pp.89-114, 1996. ,
Some adaptive Monte Carlo methods for Bayesian inference, Statistics in Medicine, vol.43, issue.17-18, pp.2507-2515, 1888. ,
DOI : 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2507::AID-SIM272>3.0.CO;2-J
Structured Markov Chain Monte Carlo, Journal of Computational and Graphical Statistics, vol.92, issue.2, pp.217-234, 2000. ,
DOI : 10.1080/10618600.2000.10474877
Pharmacokinetic models in the development of exposure indicators in epidemiology, Ann Occup Hyg, vol.35, pp.543-560, 1991. ,
The Bayesian Modeling of Covariates for Population Pharmacokinetic Models, Journal of the American Statistical Association, vol.43, issue.435, pp.917-927, 1996. ,
DOI : 10.2307/2986121
Analysis of PBPK Models for Risk Characterization, Annals of the New York Academy of Sciences, vol.43, issue.9, pp.317-337, 1999. ,
DOI : 10.1016/0041-008X(90)90037-U
URL : https://hal.archives-ouvertes.fr/ineris-00962759
Statistical Analysis of Clewell et al. PBPK Model of Trichloroethylene Kinetics, Environmental Health Perspectives, vol.108, issue.s2, pp.307-316, 2000. ,
DOI : 10.1289/ehp.00108s2307
URL : https://hal.archives-ouvertes.fr/ineris-00961854